v3.19.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Cash flows from operating activities:    
Net income (loss) [1] $ (5,718,000) $ (1,780,000)
Reconciliation of net loss to net cash used in operating activities:    
Depreciation and amortization 942,000 2,113,000
Stock-based compensation 445,000 586,000
Loss (gain) on sale of fixed assets 11,000 (1,000)
Exchange rate loss (gain) 3,000 1,000
Changes in assets and liabilities:    
Accounts receivable 1,829,000 1,914,000
Inventories 1,483,000 (1,148,000)
Prepaid expenses and other current assets (122,000) (315,000)
Other assets (638,000) 1,000
Deferred revenue (707,000) (655,000) [2]
Accounts payable and accrued expenses 950,000 770,000
Net cash provided by (used in) operating activities (1,544,000) 1,488,000
Cash flows from investing activities:    
Maturities of other short-term investments   2,779,000
Purchase of product licensing rights (1,950,000) [3] 0
Purchases of property and equipment (59,000) (153,000)
Net cash provided by (used in) investing activities (2,009,000) 2,626,000
Cash flows from financing activities:    
Purchases of treasury stock (189,000) (605,000)
Net cash provided by (used in) financing activities (189,000) (605,000)
Gain (loss) of exchange rate changes on cash 1,000 (1,000)
Net increase (decrease) in cash and cash equivalents (3,741,000) 3,508,000
Net increase (decrease) in cash and cash equivalents 25,457,000 24,963,000
Cash and cash equivalents, end of period $ 21,716,000 $ 28,471,000
[1] Net income (loss) and comprehensive income (loss) are the same for the periods reported.
[2] Includes the cumulative effect adjustment of the ASC 606 adoption.
[3] During the quarter ended September 30, 2019, the Company made a $950,000 payment for the purchase of product licensing rights. The remaining $1.0 million that is due is recorded in Accounts Payable as of September 30, 2019. The corresponding asset is recorded in intangible assets.

Source